Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Antengene's ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma
2025-08-19 13:26
Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease
2025-08-19 11:00
RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries
2025-08-19 08:00
Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP).
2025-08-18 21:00
KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS
2025-08-18 18:29
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the Taiwan Food and Drug Administration for the Treatment of Moderately to Severely Active Ulcerative Colitis
2025-08-14 12:02
KBP's Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration
2025-08-13 09:44
WuXi Biologics' WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale
2025-08-12 17:00
Intas & Accord signs Agreement to acquire Prothya Biosolutions
2025-08-11 21:41
Everest Medicines to Announce 2025 Interim Results on August 29, 2025
2025-08-11 17:11
WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules
2025-08-11 16:30
HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment
2025-08-11 09:00
Brain Navi Biotechnology's NaoTrac performs first surgeries in Spain
2025-08-11 09:00
RemeGen's Independently-Developed Bispecific Antibody RC148 Approved to Proceed Phase II Clinical Trial in US by FDA
2025-08-08 17:50
Codex Genetics Expands Precision Oncology Portfolio with Cxbladder Genomic Urine Tests
2025-08-08 17:45
WCC Biomedical@NACDS Total Store Expo: Advancing Microneedle Drug Delivery With WINMAP™ Platform
2025-08-08 09:30
LabConnect Partners with Kits4Life to Reduce Kit Waste and Advance Sustainable Clinical Trials
2025-08-08 00:40
XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration
2025-08-07 08:05
New revolutionary brain tech platform 'ScreenIT' puts smarter concussion care in reach
2025-08-06 06:16
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
2025-08-05 18:40
1
11
12
13
14
15
264